Venture Capital

What the $941 million Q1 2026 number tells us about MENA

MENA startup funding fell to 941 million dollars in the first quarter of 2026, marking a 37 percent drop year on year and a 21.5 percent decline from the previous quarter, and the numbers behind that headline tell a story that goes well beyond a single difficult quarter. Geopolitical disruption, a near standstill in March deal activity, and a persistent gender funding gap are the details that the aggregate figure alone does not show.

The two numbers that determine how much your company you actually keep

The difference between pre-money and post-money valuation is four words and one equation, but getting it wrong on a term sheet can cost a founder several percentage points of their company before they have signed a single customer. Understanding which number you are negotiating and what it implies for your ownership is not optional financial literacy. It is the most basic thing you need to know before you sit across from an investor.

Managing investor relationships between rounds before the next raise begins

The Series B is where a lot of founders discover that the relationship they built with their Series A investor matters just as much as the traction they built in the market. An investor who felt informed, respected, and genuinely partnered through the Series A period is an asset when the B round opens. An investor who felt surprised, managed, or sidelined is a complication you will be negotiating around at exactly the moment you need clean momentum.

Why the valuation cap on your SAFE matters more than anything else in it

A SAFE feels simple until it converts, and by the time most founders understand what the valuation cap actually meant, the dilution has already happened. The cap is not a formality in the document. It is the number that determines how much of your company you actually gave away, and getting it wrong at the pre-seed stage can follow you through every round that comes after.

Why fake customer advocates hurt founders more than honest feedback ever could

Customer calls are not a formality in the investor due diligence process. They are often the moment a deal is made or quietly killed, and the founders who treat them as a box to check rather than a validation exercise they need to actively prepare for almost always pay for that mistake.

Why your walk-away number matters more than your target valuation

An investor offering five million dollars at a fifteen million dollar valuation when you were expecting twenty is not a rejection. It is the opening position in a negotiation that most founders are underprepared for, and the way you respond in the next forty-eight hours will determine not just the terms of this deal but the tone of the entire relationship that follows.

The honest trade-off between bootstrapping and raising for MENA founders

The startup world has spent a decade treating fundraising as a milestone rather than a tool, but the founders who build the most durable companies are the ones who ask a simpler question first: do I actually need someone else's money to win? The answer depends on your market, your margins, your psychology, and how much of your company you are willing to trade for speed you may not need.

Why CVCs are different and how to get them to write you a check

Corporate venture capital can open doors that no financial investor can match, but only if you understand what corporate investors are actually buying. Unlike traditional VCs, firms like Aramco Ventures, STC Ventures, and e& Capital are not writing checks for returns alone — they are investing in strategic relevance, and founders who pitch without understanding that distinction rarely make it past the first meeting.

Angel Investors and Venture Capitalists: What every founder needs to know before raising

An angel investor is an individual who invests their own money, makes their own decisions, and often moves quickly because there is no committee to convince. A venture capital firm, on the other hand, is an institution that manages a fund raised from limited partners and answers to those LPs, meaning every investment decision carries institutional weight and takes considerably longer.

Term sheet clauses every MENA founder must understand

Most founders read a term sheet the way most people read a terms-and-conditions page — quickly, optimistically, and with a quiet faith that everything will probably be fine. It rarely is. Buried inside the standard language are three clauses that will determine, far more than your ownership percentage ever will, how much money you actually walk away with when your company exits. Get the valuation math wrong and you lose equity before the ink dries. Accept a participating liquidation preference without understanding it and an investor can take the majority of a modest exit while you held the majority of the company. Sign a full ratchet anti-dilution clause and a single down round can halve your ownership without you raising another dollar. This guide breaks down each clause plainly, shows you what the numbers actually look like, and tells you what to fight, what to accept, and what should make you walk away from the table entirely.

Women's health giant Hologic completes transition to private ownership under Blackstone and TPG

Hologic has completed its transition from a Nasdaq-listed company to a privately held entity, following the close of its $18.3 billion acquisition by Blackstone and TPG. The deal brings fresh capital and strategic backing to one of the world's foremost companies dedicated to advancing women's health.

What MENA investors actually want — the unwritten rules nobody puts in their thesis

We sat with five investors across Karachi, Dubai, and Riyadh and asked them to be honest. What came back wasn't the standard pitch advice. It was the stuff they talk about after you leave the room.

WHOOP attracts Gulf sovereign funds and global athletes in $575M round

The math of ownership: what founders actually keep after raising money

Most founders know dilution is coming. Few understand how fast it compounds. By the time you reach Series B, the cap table you started with looks nothing like the one you have now — and the difference is not just the rounds you raised.

The dilution math every founder needs to know before raising a round

Sixty-nine percent of co-founders in digital health IPOs owned less than five percent of their company when they went public. Forty-four percent had no reported equity at all. The median individual founder ownership at IPO was just two percent. Those numbers should make every founder sit up straight. But here is the caveat. Those are digital health companies. They eat cash for breakfast. A lean B2B SaaS startup with good unit economics will do much better. Still, the trend is real. Founder ownership gets eaten alive by funding rounds. The question is not whether you will get diluted. You will. The question is how much you can protect, and whether what is left at the end is worth the years you gave. This guide walks through the math in plain English. No complex spreadsheets. Just clear numbers, real examples from Careem and Daraz, and the legal stuff you actually need to know. From the option pool shuffle to anti-dilution clauses, here is what founders should understand before they sign their first term sheet.

Egyptian fintech Lucky secures $23M Series B as it expands consumer credit into Tunisia and Morocco

The complete fundraising timeline 12 weeks from first meeting to investment

Successful MENA startups typically close funding rounds within 12 weeks of initial investor contact, though Saudi deals extend to 16 weeks due to regulatory requirements. This comprehensive timeline breaks down each phase from first meetings through deal closing.

From dilution to repayment understanding the real trade offs between Equity and Revenue based financing for SaaS

From Karachi to Dubai: A Founder's Guide to Raising the Right Amount at the Right Valuation